Vet Med - Czech, 2018, 63(10):443-467 | DOI: 10.17221/31/2018-VETMED

Epigallocatechin gallate: a reviewReview

L. Bartosikova*, J. Necas
Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic

Epigallocatechin gallate is the major component of the polyphenolic fraction of green tea and is responsible for most of the therapeutic benefits of green tea consumption. A number of preclinical in vivo and in vitro experiments as well as clinical trials have shown a wide range of biological and pharmacological properties of polyphenolic compounds such as anti-oxidative, antimicrobial, anti-allergic, anti-diabetic, anti-inflammatory, anti-cancer, chemoprotective, neuroprotective and immunomodulatory effects. Epigallocatechin gallate controls high blood pressure, decreases blood cholesterol and body fat and decreases the risk of osteoporotic fractures. Further research should be performed to monitor the pharmacological and clinical effects of green tea and to more clearly elucidate its mechanisms of action and the potential for its use in medicine.

Keywords: epigallocatechin-3-O-gallate; pharmacokinetics; toxicity; biological activity

Published: October 31, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartosikova L, Necas J. Epigallocatechin gallate: a review. Vet Med - Czech. 2018;63(10):443-467. doi: 10.17221/31/2018-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ahmed S, Pakozdi A, Koch AE (2006): Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis & Rheumatology 54, 2393-2401. Go to original source... Go to PubMed...
    2. Anderson RF, Fisher LJ, Hara Y, Harris T, Mak WB, Melton LD, Packer JE (2001): Green tea catechins partially protect DNA from (x2219)OH radical induced strand breaks and base damage through fast chemical repair of DNA radicals. Carcinogenesis 22, 1189-1193. Go to original source... Go to PubMed...
    3. Babu A, Liu D (2008): Green tea catechins and cardiovascular health: an update. Current Medicinal Chemistry 15, 1840-1850. derstanding the anti-diabetic actions of dietary flavonoids. Journal of Nutritional Biochemistry 24, 1777-1789. Go to original source... Go to PubMed...
    4. Bai XC, Lu D, Bai J, Zhenq H, Ke ZY, Li XM, Luo SQ (2004): Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB. Biochemical and Biophysical Research Communication 314, 197-207. Go to original source... Go to PubMed...
    5. Banfi G, Iorio EL, Corsi MM (2008): Oxidative stress, free radicals and bone remodeling. Clinical Chemistry and Laboratory Medicine 46, 1550-1555. Go to original source... Go to PubMed...
    6. Basu K, Michaelsson H, Olofsson H, Johansson S, Melhus H (2001): Association between oxidative stress and bone mineral density. Biochemical and Biophysical Research Communication 88, 275-279. Go to original source... Go to PubMed...
    7. Baumann D, Adler S, Hamburger M (2001): A simple isolation method for the major catechins in green tea using high-speed countercurrent chromatography. Journal of Natural Products 64, 353-355. Go to original source... Go to PubMed...
    8. Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, Horneber M (2009): Green tea (Camellia sinensis) for the prevention of cancer (Review). The Cochrane Library 3, doi: 10.1002/14651858.CD005004.pub2. Go to original source... Go to PubMed...
    9. Bonkovsky HL (2006): Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Annals of Internal Medicine 144, 68-71. Go to original source... Go to PubMed...
    10. Borzelleca JF (2004): A critical evaluation of the information and data submitted on the safety of EGCG, Epigallocatechin gallate (TEAVIGOTM). Available at www.teavigoinfo.com/pdf/medical-safety-opinion.pdf.
    11. Boschmann M, Thielecke F (2007): The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. Journal of the American College of Nutrition 26, 389S-395S. Go to original source... Go to PubMed...
    12. Britschgi A, Simon HU, Tobler A, Fey MF, Tschan MP (2010): Epigallocatechin-3gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acidinduced neutrophil differentiation via death-associated protein kinase 2. British Journal of Haematology 149, 55-64. Go to original source... Go to PubMed...
    13. Bursill CHA, Roach PD (2006): Modulation of cholesterol metabolism by the green tea polyphenol (-)-epigallocatechin gallate in cultured human liver (HepG2) cells. Journal of Agricultural and Food Chemistry 54, 1621-1626. Go to original source... Go to PubMed...
    14. Cai EP, Lin JK (2009): Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signalling in rat pancreatic beta cells. Journal of Agricultural and Food Chemistry 57, 9817-9827. Go to original source... Go to PubMed...
    15. Cai Y, He SQ, Hong HQ, Cai YP, Zhao L, Zhang M (2015): High doses of (2)-epigallocatechin-3-gallate from green tea induces cardiac fibrosis in mice. Biotechnology Letters 37, 2371-2377. Go to original source... Go to PubMed...
    16. Calland N, Albecka A, Belouzard S, Wychowski C, Duverlie G, Descamps V, Hober D, Dubuisson J, Rouille Y, Seron K (2012): (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology 55, 720-729. Go to original source... Go to PubMed...
    17. Camouse MM, Domingo DS, Swain FR, Conrad EP, Matsui MS, Maes D, Declerq L, Cooper KD, Stevens SR, Baron ED (2009): Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin. Experimental Dermatology 18, 522-526. Go to original source... Go to PubMed...
    18. Chacko SM, Thambi PT, Kuttan R, Nishigaki I (2010): Beneficial effects of green tea: A literature review. Chinese Medicine 5, 13. Go to original source... Go to PubMed...
    19. Chang LK, Wei TT, Chiu YF, Tung CP, Chuang JY, Hung SK, Li C, Liu ST (2003): Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate. Biochemical and Biophysical Research Communication 301, 1062- 1068. Go to original source... Go to PubMed...
    20. Chen C, Qui H, Gong J, Liu Q, Xiao H, Chen XW, Sun BL, Yanq RG (2012): (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus. Archives of Virology 157, 1301-1312. Go to original source... Go to PubMed...
    21. Chen L, Lee MJ, Li H, Yang CS (1997): Absorption, distribution and elimination of tea polyphenols in rats. Drug Metabolism and Disposition 25, 1045-1050.
    22. Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, Dorr RT, Hara Y, Alberts DS (2003): Pharmacokinetics and Safety of green tea polyphenols after multipledose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clinical Cancer Research 9, 3312-3319.
    23. Clifford MN, van der Hooft JJJ, Crozier A (2013): Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols. American Journal of Clinical Nutrition 98, 1619S-1630S. Go to original source... Go to PubMed...
    24. Cooper R, Morre DJ, Morre DM (2005): Medicinal benefits of green tea: Part I. Review of noncancer health benefits. Journal of Alternative and Complement Medicine 11, 521-528. Go to original source... Go to PubMed...
    25. Crowell JA, Swezey RR, Chow HHS, Hara Y (2005): The pharmacokinetics of EGCG: Preclinical and clinical studies. Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892. Available at www. ocha-festival.jp/archive/english/conference/ICOS2001/ files/PROC/III-103.pdf.
    26. Dalluge JJ, Nelson BC (2000): Determination of tea catechins. Journal of Chromatography A 881, 411-424. Go to original source... Go to PubMed...
    27. Das S, Tanwar J, Hameed S, Fatima Z (2014): Antimicrobial potential of epigallocatechin-3-gallate (EGCG): a green tea polyphenol. Journal of Biochemical and Pharmacological Research 2, 167-174.
    28. Deka A, Vita JA (2011): Tea and cardiovascular disease. Pharmacological Research 64, 136-145. Go to original source... Go to PubMed...
    29. Deng YT, Chang TW, Lee MS, Lin JK (2012): Suppression of free fatty acid-induced insulin resistance by phytopolyphenols in C2C12 mouse skeletal muscle cells. Journal of Agricultural and Food Chemistry 60, 1059-1066. Go to original source... Go to PubMed...
    30. Dong Z (2000): Effects of food factors on signal transduction pathways. Biofactors 12, 17-28. Go to original source... Go to PubMed...
    31. Du GJ, Zhang Z, Wen XD, Yu C, Calway T, Yuan CS, Wanq CZ (2012): Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients 4, 1679-1691. Go to original source... Go to PubMed...
    32. Dudaric L, Fuzinac-Smojver A, Muhvic D, Giacometti J (2015): The role of polyphenols on bone metabolism in osteoporosis. Food Research International 77, 290-298. Go to original source...
    33. Duenas SC, Fabregas PS, Durandez R (2004): Hepatotoxicity due to Camelia sinensis. Medicina Clinica (Barcelona) 122, 677-678. Go to original source...
    34. el Wafa Abu Y, Benavente AF, Talavera AF, Perez MR, Ramos-Clemente JI (2005): Acute hepatitis induced by Camellia sinensis (green tea). Anales de Medicina Interna 22, 298. Available at www.ncbi.nlm.nih.gov/pubmed/16145729. Go to original source... Go to PubMed...
    35. Ellis D (2002): Amphotericin B: Spectrum and resistance. Journal of Antimicrobial Chemotherapy 49, 7-10. Go to original source... Go to PubMed...
    36. Fassina G, Buffa A, Benelli R, Varnier OE, Noonan DM, Albini A (2002): Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS 16, 939-941. Go to original source... Go to PubMed...
    37. Fatokun AA, Stone TW, Smith RA (2008): Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species. European Journal of Pharmacology 87, 35-41. Go to original source... Go to PubMed...
    38. Forester SC, Lambert JD (2011): Antioxidant effects of green tea. Molecular Nutrition and Food Research 55, 844-854. Go to original source... Go to PubMed...
    39. Frank J, George TW, Lodge JK, Rodriguez-Mateos AM, Spencer JPE, Minihane AM, Rimbach G (2009): Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. Journal of Nutrition 139, 58-62. Go to original source... Go to PubMed...
    40. Fujiki H, Imai K, Nakachi K, Sueoka E, Watanabe T, Suganuma M (2015): Innovative strategy of cancer treatment with the combination of green tea catechins and anticancer compounds. Cancer Cell and Microenvironment 2, 1-7.
    41. Galati G, Lin A, Sultan AM, O'Brien PJ (2006): Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radical Biology and Medicine 40, 570-580. Go to original source... Go to PubMed...
    42. Garcia-Moran S, Saez-Royuela F, Gento E, Lopez Morante A, Arias L (2004): Acute hepatitis associated with Camellia thea and Orthosiphon stamineus ingestion. Gastroenterology and Hepatology 27, 559-560. Go to original source... Go to PubMed...
    43. Gradisar H, Pristovsek P, Plaper A, Jerala R (2007): Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site. Journal of Medicinal Chemistry 50, 264-271. Go to original source... Go to PubMed...
    44. Granja A, Pinheiro M, Reis S (2016): Epigallocatechin gallate nanodelivery systems for cancer therapy. Nutrients 8, 1-23. Go to original source... Go to PubMed...
    45. Green CJ, Macrae K, Fogarty S, Hardie DG, Sakamoto K, Hundal HS (2011): Countermodulation of fatty acid-induced pro-inflammatory nuclear factor kappa B signalling in rat skeletal muscle cells by AMP-activated protein kinase. Biochemical Journal 435, 463-474. Go to original source... Go to PubMed...
    46. Grinberg LN, Newmark H, Kitrossky N, Rahamim E, Chevion M, Rachmilewitz EA (1997): Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochemical Pharmacology 54, 973-978. Go to original source... Go to PubMed...
    47. Gu JW, Makey KL, Tucker KB, Chinchar E, Mao X, Pei I, Thomas EY, Miele L (2013): EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression. Vascular Cell 5, 9. Go to original source... Go to PubMed...
    48. Guo Q, Zhao B, Li M, Shen S, Xin W (1996): Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochimica et Biophysica Acta 1304, 210-222. Go to original source... Go to PubMed...
    49. Gupta S, Ahmad N, Nieminen AL, Mukhtar H (2000): Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin3-gallate in androgen sensitive and androgen-insensitive human prostate carcinoma cells. Toxicology and Applied Pharmacology 164, 82-90. Go to original source... Go to PubMed...
    50. Hashimoto R, Yaita M, Tanaka K, Hara Y, Kojo S (2000): Inhibition of radical reaction of apolipoprotein B-100 and alpha-tocopherol in human plasma by green tea catechins. Journal of Agricultural and Food Chemistry 48, 6380-6383. Go to original source... Go to PubMed...
    51. Hayashi K, Takai S, Matsushima-Nishiwaki R, Hanai Y, Kato K, Kozawa O (2008): (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stressactivated protein kinase/c-Jun N-terminal kinase in osteoblasts. Life Sciences 82, 1012-1017. Go to original source... Go to PubMed...
    52. He W, Li LX, Liao QJ, Liu CL, Chen XL (2011): Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line. World Journal of Gastroenterology 17, 1507-1514. Go to original source... Go to PubMed...
    53. Hirasawa M, Takada K (2004): Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. Journal of Antimicrobial Chemotherapy 53, 225-229. Go to original source... Go to PubMed...
    54. Hirsova P, Kolouchova G, Dolezelova E, Cermanova J, Hispler R, Kadova Z, Micuda S (2012): Epigallocatechin gallate enhances biliary cholesterol secretion in healthy rats and lowers plasma and liver cholesterol in ethinylestradioltreated rats. European Journal of Pharmacology 691, 38-45. Go to original source... Go to PubMed...
    55. Ho Y, Lee YL, Hsu KY (1995): Determination of (+)-catechin in plasma by high-performance liquid chromatography using fluorescence detection. Journal of Chromatography B: Biomed Sciences and Applications 665, 383-389. Go to original source... Go to PubMed...
    56. Hong JY, Yon J, Lee JS, Lee IK, Yang C, Kim MS, Choi SH, Jung UW (2015): Effects of epigallocatechin-3-gallate on the healing of extraction sockets with a periapical lesion: A pilot study in dogs. Journal of Biomedical Materials Research Part B: Applied Biomaterials 103, 727-734. Go to original source... Go to PubMed...
    57. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A (2008): Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition 88, 38-50. Go to original source... Go to PubMed...
    58. Horie H, Mukai T, Kohata K (1997): Simultaneous determination of qualitatively important components in green tea infusions using capillary electrophoresis. Journal of Chromatography A 758, 332-335. Go to original source...
    59. Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P (2008): Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clinical Nutrition 27, 363-370. Go to original source... Go to PubMed...
    60. Huang Y, Kumazoe M, Bae J, Yamada S, Takai M, Hidaka S, Yamashita S, Kim Y, Won Y, Murata M, Tsukamoto S, Tachibana H (2015): Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells. Oncology Reports 34, 1162-1168. Go to original source... Go to PubMed...
    61. Imanishi H, Sasaki YF, Ohta T, Watanabe M, Kato T, Shirasu Y (1991): Tea tannin components modify the induction of sister chromatid exchanges and chromosome aberrations in mutagen-treated cultured mammalian cells and mice. Mutation Research/Genetic Toxicology 259, 79-81. Go to original source... Go to PubMed...
    62. Imanishi N, Tuji Y, Katada Y, Maruhashi M, Konosu S, Mantani N, Terasawa K, Ochiai H (2002): Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiology and Immunology 46, 491-494. Go to original source... Go to PubMed...
    63. Isbrucker RA, Bausch J, Edwards JA, Wolz E (2006c): Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: Genotoxicity. Food and Chemical Toxicology 44, 626-635. Go to original source... Go to PubMed...
    64. Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J (2006a): Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and shortterm toxicity studies. Food and Chemical Toxicology 44, 636-650. Go to original source... Go to PubMed...
    65. Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J (2006b): Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: Teratogenicity and reproductive toxicity studies in rats. Food and Chemical Toxicology 44, 651-661. Go to original source... Go to PubMed...
    66. Janjua R, Munoz C, Gorell E, Rehmus W, Eqbert B, Kern D, Chanq AL (2009): A two-year, double-blind, randomized placebo-controlled trial of oral green tea polyphenols on the long-term clinical and histologic appearance of photoaging skin. Dermatologic Surgery 35, 1057-1065. Go to original source... Go to PubMed...
    67. Jimenez-Saenz M, Martinez-Sanchez C (2007): Green tea extracts and acute liver failure: The need for caution in their use and diagnostic assessment. Liver Transplantation 13, 1067. Go to original source... Go to PubMed...
    68. Kamon M, Zhao R, Sakamoto K (2009): Green tea polyphenol (-)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells. Cell Biology International 34, 109-116. Go to original source... Go to PubMed...
    69. Kashima M (1999): Effects of catechins on superoxide and hydroxyl radical. Chemical and Pharmacological Bulletin (Tokyo) 47, 279-283. Go to original source... Go to PubMed...
    70. Kawai K, Tsuno NH, Kitayama J, Okaji Y, Yazawa K, Asakage M, Hori N, Watanabe E, Takahashi K, Nagawa H (2003): Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. Journal of Allergy and Clinical Immunology 112, 951-957. Go to original source... Go to PubMed...
    71. Kelly MR, Geigerman CM, Loo G (2001): Epigallocatechin gallate protects U937 cells against nitric oxide-induced cell cycle arrest and apoptosis. Journal of Cellular Biochemistry 81, 647-658. Go to original source... Go to PubMed...
    72. Khan N, Afaq F, Mukhtar H (2008): Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxidants and Redox Signaling 10, 475-510. Go to original source... Go to PubMed...
    73. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H (2006): Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Research 66, 2500-2505. Go to original source... Go to PubMed...
    74. Khan SH (2014): The use of green tea (Camellia sinensis) as a phytogenic substance in poultry diets. Onderstepoort Journal of Veterinary Research 81, 1-8. Go to original source... Go to PubMed...
    75. Khandelwal A, Hall JA, Blagg BS (2013): Synthesis and structure-activity relationships of EGCG analogues, a recently identified Hsp90 inhibitor. Journal of Organic Chemistry 78, 7859-7884. Go to original source... Go to PubMed...
    76. Khurshid Z, Zafar MS, Zohaib S, Najeeb S, Naseem M (2016): Green tea (Camellia sinensis): Chemistry and oral health. The Open Dentistry Journal 10, 166-173. Go to original source... Go to PubMed...
    77. Kim DC, Lim JS (1999): Pharmacokinetic study of epigallocatechin gallate in rats. Journal of Korean Pharmaceutical Sciences 29, 179-184.
    78. Kim HS, Quon MJ, Kim J (2014a): New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biology 2, 187-195. Go to original source... Go to PubMed...
    79. Kim SJ, Amankwah E, Connors S, Park HY, Rincon M, Cornnell H, Chornokur G, Hashim AI, Choi J, Tsai YY, Engelman RW, Kumar N, Park JY (2014b): Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice. Cancer Prevention Research 7, 435-444. Go to original source... Go to PubMed...
    80. Koh SH, Kim SH, Kwon H, Park Y, Kim KS, Song CW, Kim J, Kim MH, Yu HJ, Henkel JS, Junq HK (2003): Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3. Molecular Brain Research 118, 72-81. Go to original source... Go to PubMed...
    81. Kumazoe M, Kim Y, Bae J, Takai M, Murata M, Suemasu Y, Sugihara K, Yamashita S, Tsukamoto S, Huang Y, Nakahara K, Yamada K, Tachibana H (2013a): Phosphodiesterase 5 inhibitor acts as a potent agent sensitizing acute myeloid leukemia cells to 67-kDa laminin receptor-dependent apoptosis. FEBS Letters 587, 3052-3057. Go to original source... Go to PubMed...
    82. Kumazoe M, Sugihara K, Tsukamoto S, Huang Y, Tsurudome Y, Suzuki T, Suemasu Y, Ueda N, Yamashita S, Kim Y, Yamada K, Tachibana H (2013b): 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. Journal of Clinical Investigation 123, 787-799. Go to original source... Go to PubMed...
    83. Kumazoe M, Tachibana H (2016): Anti-cancer effect of EGCG and its mechanisms. Functional Foods in Health and Disease 6, 70-78. Go to original source...
    84. Kumazoe M, Tsukamoto S, Lesnick C, Kay NE, Yamada K, Shanafelt TD, Tachibana H (2015): Vardenafil a clinically available phosphodiesterase inhibitor potentiates the killing effect of EGCG on CLL cells. British Journal of Haematology 168, 610-613. Go to original source... Go to PubMed...
    85. Lambert JD, Elias RJ (2010): The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Archives of Biochemistry and Biophysics 501, 65-72. Go to original source... Go to PubMed...
    86. Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, Yang CS (2010): Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food and Chemical Toxicology 48, 409-416. Go to original source... Go to PubMed...
    87. Lambert JD, Sang S, Yang CS (2007): Biotransformation of green tea polyphenols and the biological activities of those metabolites. Molecular Pharmaceutics 4, 819-825. Go to original source... Go to PubMed...
    88. Lambert JD, Yand CS (2003): Mechanisms of cancer prevention by tea constituents. Journal of Nutrition 133, 3262S- 3267S. Go to original source... Go to PubMed...
    89. Landis-Piwowar KR, Kuhn DJ, Wan SB, Chen D, Chan TH, Dou QP (2005): Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs. International Journal of Molecular Medicine 15, 735-742. Go to original source...
    90. Lecumberri E, Dupertuis YM, Mirabell R, Pichard C (2013): Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clinical Nutrition 32, 894-903. Go to original source... Go to PubMed...
    91. Lee KM, Yeo M, Choue JS, Jin JH, Park SJ, Cheong JY, Lee KJ, Kim JH, Hahm KB (2004): Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori - induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling. Helicobacter 9, 632-642. Go to original source... Go to PubMed...
    92. Lee MJ, Maliakal P, Chen L, Menq X, Bondoc FY, Prabhu S, Lambert G, Mohr S, Yanq CS (2002): Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiology, Biomarkers and Prevention 11, 1025- 1032.
    93. Lee MJ, Wang ZY, Li H, Chen L, Sun Y, Gobbo S, Balentine DA, Yanq CS (1995): Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiology, Biomarkers and Prevention 4, 393-399.
    94. Lemieux K, Konrad D, Klip A, Marette A (2003): The AMPactivated protein kinase activator AICAR does not induce GLUT4 translocation to transverse tubules but stimulates glucose uptake and p38 mitogen-activated protein kinases alpha and beta in skeletal muscle. FASEB Journal 17, 1658-1665. Go to original source... Go to PubMed...
    95. Li YH, Wu Y, Wei HC, Xu YY, Jia LL, Chen J, Yanq XS, Donq GH, Gao XH, Chen HD (2009): Protective effects of green tea extracts on photoaging and photo immunosuppression. Skin Research and Technology 15, 338-345. Go to original source... Go to PubMed...
    96. Liang YC, Lin-Shiau SY, Chen CF, Lin JK (1999): Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast cancer carcinoma cells by (-)-epigallocatechin-3-gallate. Journal of Cellular Biochemistry 75, 1-12. Go to original source...
    97. Lim SH, Kim HS, Kim YK, Kim TM, Im S, Chung ME, Hong BY, Ko YJ, Kim HW, Lee JI (2010): The functional effect of epigallocatechin gallate on ischemic stroke in rats, Acta Neurobiologiae Experimentalis 70, 40-46. Go to original source...
    98. Lipinski K, Mazur M, Antoszkiewicz Z, Purwin C (2017): Polyphenols in monogastric nutrition - a review. Annals of Animal Science 17, 41-58. Go to original source...
    99. Liu L, Sun L, Zhang H, Li Z, Ning X, Shi Y, Guo C, Han S, Wu K, Fan D (2009): Hypoxia-mediated up-regulation of MGr1-Ag/37LRP in gastric cancers occurs via hypoxiainducible-factor 1-dependent mechanism and contributes to drug resistance. International journal of cancer. International Journal of Cancer 124, 1707-1715. Go to original source... Go to PubMed...
    100. Locher R, Emmanuele L, Suter PM, Vetter W, Barton M (2002): Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein. European Journal of Pharmacology 434, 1-7. Go to original source... Go to PubMed...
    101. Lorenz M, Rauhut F, Hofer C, Gwosc S, Muller E, Praeger D, Zimmermann BF, Wernecke KD, Baumann G, Stangl K, Stangl V (2017): Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG). Scientific Reports 7, 1-10. Go to original source... Go to PubMed...
    102. Lotito SB, Fraga CG (2000): Catechins delay lipid oxidation and alphatocopherol and beta-carotene depletion following ascorbate depletion in human plasma. Proceedings of the Society for Experimental Biology and Medicine 225, 32-38. Go to original source... Go to PubMed...
    103. Mahler A, Mandel S, Lorenz M, Ruegg U, Wanker EE, Boshmann M, Paul F (2013): Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? EPMA Journal 4, 1-17. Go to original source... Go to PubMed...
    104. Maki KC, Reeves MS, Farmer M, Yasunaga K, Matsuo N, Katsuragi Y, Komikado M, Tokimitsu I, Wilder D, Jones F, Blumberg JB, Cartwright Y (2009): Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. Journal of Nutrition 139, 264-270. Go to original source... Go to PubMed...
    105. Manolagas SC (2008): De-fense! De-fense! De-fense: scavenging H2O2 while making cholesterol. Endocrinology 149, 3264-3266. Go to original source... Go to PubMed...
    106. Manolagas SC, Parfitt AM (2010): What old means to bone. Trends in Endocrinology and Metabolism 21, 369-374. Go to original source... Go to PubMed...
    107. Matsubara S, Shibata H, Ishikawa F, Yokokura T, Takahashi M, Sugimura T, Wakabayshi K (2003): Suppression of Helicobacter pylori-induced gastritis by green tea extract in Mongolian gerbils. Biochemical and Biophysical Research Communication 310, 715-719. Go to original source... Go to PubMed...
    108. Matsuyama T, Tanaka Y, Kamimaki I, Nagao T, Tokimitsu I (2008): Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity 16, 1338-1348. Go to original source... Go to PubMed...
    109. Mazzanti G, Menniti-Ippolito F, Moro PA, Casetti F, Raschetti R, Santuccio C, Mastrangelo S (2009): Hepatotoxicity from green tea: a review of the literature and two unpublished cases. European Journal of Clinical Pharmacology 65, 331-341. Go to original source... Go to PubMed...
    110. Meng X, Sang S, Zhu N, Lu H, Sheng S, Lee MJ, Ho CT, Yang CS (2002): Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chemical Research in Toxicology 15, 1042-1050. Go to original source... Go to PubMed...
    111. Merck (1997): (-)-Epigallocatechin gallate. 3568. The Merck Index. 12th edn. On CD-ROM. Chapman and Hall, London.
    112. Mereles D, Hunstein W (2011): Epigallocatechin-3-gallate (EGCG) for clinical trials: More pitfalls than promises? Review. International Journal of Molecular Sciences 12, 5592-5603. Go to original source... Go to PubMed...
    113. Min K, Kwon TK (2014): Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate. Review article. Integrative Medicine Research 3, 16-24. Go to original source... Go to PubMed...
    114. Minocha R, Dani HM, Siddiqi MA (1986): Evaluation of carcinogenicity of infusions from green tea leaves by microsomal degranulation technique. Indian Journal of Experimental Biology 24, 224-228.
    115. Mody N, Parhami F, Saraflan TA, Demer LL (2001): Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radical Biology and Medicine 31, 509-519. Go to original source... Go to PubMed...
    116. Momose Y, Yamamoto MM, Nabetani H (2016): Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans. Comprehensive review. International Journal of Food Sciences and Nutrition 67, 606-613. Go to original source... Go to PubMed...
    117. Moradzadeh M, Hosseini A, Erfanian S, Rezaei H (2017): Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase. Pharmacological Reports 69, 924-928. Go to original source... Go to PubMed...
    118. Nagle DG, Ferreira D, Zhou YD (2006): Epigallocatechin3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry 67, 1849-1855. Go to original source... Go to PubMed...
    119. Nakagawa K, Miyazawa T (1997): Absorption and distribution of tea catechin (-)-epigallocatechin-3-gallate in the rat. Journal of Nutritional Science and Vitaminology 43, 679-684. Go to original source... Go to PubMed...
    120. Nanjo F, Mori M, Goto K, Hara Y (1999): Radical scavenging activity of tea catechins and their related compounds. Bioscience, Biotechnology and Biochemistry 63, 1621-1623. Go to original source... Go to PubMed...
    121. Nantz MP, Rowe CA, Bukowski JF, Percival SS (2009): Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition 25, 147-154. Go to original source... Go to PubMed...
    122. Narotzki B, Reznick AZ, Aizenbud D, Levy Y (2012): Green tea: A promising natural product in oral health. Archives of Oral Biology 57, 429-435. Go to original source... Go to PubMed...
    123. Navarro-Martinez MD, Garcia-Canovas F, Rodriguez-Lopez JN (2006): Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans. Journal of Antimicrobial Chemotherapy 57, 1083-1092. Go to original source... Go to PubMed...
    124. Nelson J, McFerran NV, Pivato G, Chambers E, Doherty C, Steele D, Timson DJ (2008): The 67 kDa laminin receptor: structure, function and role in disease. Bioscience Reports 28, 33-48. Go to original source... Go to PubMed...
    125. Ohshima H, Yoshie Y, Auriol S, Gilbert I (1998): Antioxidant and pro-oxidant actions of flavonoids: Effects on DNA damage induced by nitric oxide, peroxynitrite, and nitroxyl anion. Free Radical Biology and Medicine 25, 1057-1065. Go to original source... Go to PubMed...
    126. Ortsater H, Grankvist N, Wolfram S, Kuehn N, Sjoholm A (2012): Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutrition and Metabolism 9, 11. Go to original source... Go to PubMed...
    127. Pang J, Zhao K, Wang J, Ma Z, Xiao X (2014): Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro. Journal of Zheijang University, Science B 15, 533-539. Go to original source... Go to PubMed...
    128. Pannala AS, Rice-Evans CA, Halliwell B, Singh S (1997): Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochemical and Biophysical Research Communication 232, 164-168. Go to original source... Go to PubMed...
    129. Park BJ, Taguchi H, Kamei K, Matsuzawa T, Hyon SH, Park JC (2011): In vitro antifungal activity of epigallocatechin 3-O gallate against clinical isolates of dermatophytes. Yonsei Medicine Journal 52, 535-538. Go to original source... Go to PubMed...
    130. Parmar N, Rawat M, Kumar VJ (2012): Camellia sinensis (Green tea): A review. Global Journal of Pharmacology 6, 52-59.
    131. Pedros C, Cereza G, Garcia N, Laporte JR (2003): Liver toxicity of Camellia sinensis dried etanolic extract. Medicina Clinica (Barcelona) 121, 598-599. Go to original source... Go to PubMed...
    132. Pomponio R, Gotti R, Luppi B, Cavrini V (2003): Microemulsion electrokinetic chromatography for the analysis of green tea catechins: Effect of the cosurfactant on the separation selectivity. Electrophoresis 24, 1658-1667. Go to original source... Go to PubMed...
    133. Rahmani AH, Alshabrmi FM, Allemailem KS, Aly SM, Khan MA (2015): Implications of green tea and its constituents in the prevention of cancer via the modulation of cell signalling pathway. BioMed Research International 2015, doi: 10.1155/2015/925640. Go to original source... Go to PubMed...
    134. Rao SD, Pagidas K (2010): Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells. Anticancer Research 30, 2519-2524.
    135. Ruch RJ, Cheng SJ, Klaunig JE (1989): Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea. Carcinogenesis 10, 1003-1008. Go to original source... Go to PubMed...
    136. Sang S, Lambert JD, Ho CT, Yang CS (2011): The chemistry and biotransformation of tea constituents. Pharmacological Research 64, 87-99. Go to original source... Go to PubMed...
    137. Sang S, Tian S, Wang H, Stark RE, Rosen RT, Yang CS, Ho CT (2003): Chemical studies of the antioxidant mechanism of tea catechins: radical reaction products of epicatechin with peroxyl radicals. Bioorganic and Medicinal Chemistry 11, 3371-3378. Go to original source... Go to PubMed...
    138. Sano M, Tabata M, Suzuki M, Degawa M, Miyase T, MaedaYamamoto M (2001): Simultaneous determination of twelve tea catechins by high-performance liquid chromatography with electrochemical detection. Analyst 126, 816-820. Go to original source... Go to PubMed...
    139. Scheiman J, Tseng JC, Zheng Y, Meruelo D (2009): Multiple functions of the 37/67kd laminin receptor make it a suitable target for novel cancer gene therapy. Molecular Therapy 18, 63-74. Go to original source... Go to PubMed...
    140. Schramm L (2013): Going green: The role of the green tea component EGCG in chemoprevention. Journal of Carcinogenesis and Mutagenesis 4, doi: 10.4172/21572518.1000142. Go to original source... Go to PubMed...
    141. Seeram NP, Nair MG (2002): Inhibition of lipid peroxidation and structure - activity-related studies of the dietary constituents anthocyanins, anthocyanidins, and catechins. Journal of Agricultural and Food Chemistry 50, 5308-5312. Go to original source... Go to PubMed...
    142. Shammas MA, Neri P, Koley H, Batchu RB, Bertheau RC, Munshi V, Prabhala R, Fulciniti M, Tai YT, Treon SP, Goya RK, Anderson KC, Munshi NC (2006): Specific killing of multiple myeloma cells by (-)-epigallocatechin-3gallate extracted from green tea: biologic activity and therapeutic implications. Blood 108, 2804-2810. Go to original source... Go to PubMed...
    143. Shen CL, Wang P, Guerrieri J, Yeh J, Wang JS (2008): Protective effect of green tea polyphenols on bone loss in middleaged female rats. Osteoporosis International 19, 979-990. Go to original source... Go to PubMed...
    144. Shen CL, Yeh JK, Cao J, Wang JS (2009): Green tea and bone metabolism. Nutritional Research 29, 437-456. Go to original source... Go to PubMed...
    145. Singh BN, Shankar S, Srivastava RK (2011): Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical Pharmacology 15, 1807-1821. Go to original source... Go to PubMed...
    146. Singh NA, Mandal AKA, Khan ZA (2016): Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG). Nutrition Journal 15, doi: 10.1186/s12937-016-0179-4. Go to original source... Go to PubMed...
    147. Song JM, Lee KH, Seong BL (2005): Antiviral effect of catechins in green tea on influenza virus. Antiviral Research 68, 66-74. Go to original source... Go to PubMed...
    148. Spinella F, Rosano L, Castro VD, Decandia S, Albini A, Nicotra MR, Natali PG, Bagnatao A (2006): Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma. Molecular Cancer Therapeutics 5, 1483-1492. Go to original source... Go to PubMed...
    149. Steinmann J, Buer J, Pietschmann T, Steinmann E (2013): Antiinfective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. British Journal of Pharmacology 168, 1059-1073. Go to original source... Go to PubMed...
    150. Surai PF (2013): Polyphenol compounds in the chicken/ animal diet: from the past to the future. Journal of Animal Physiology and Animal Nutrition 98, 19-31. Go to original source... Go to PubMed...
    151. Sutherland BA, Rahman RMA, Appleton I (2006): Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. Journal of Nutritional Biochemistry 17, 291-306. Go to original source... Go to PubMed...
    152. Suzuki M, Tabuchi M, Ikeda M, Umegaki K, Tomita T (2004): Protective effects of green tea catechins on cerebral ischemic damage. Medical Science Monitor 10, 166-174.
    153. Swezey R, Aldridge DE, LeValley SE, Cook S, Hara Y, Crowell JA, Hara Y, Green CE (2001): Distribution of 3H-epigallocatechin gallate (EGCG) in beagle dogs after intravenous (iv) and oral dose administration. International Journal of Toxicology 22, 187-193. Go to original source... Go to PubMed...
    154. Tachibana H (2011): Green tea polyphenol sensing. Proceedings of Japan Academy, Series B 87, 66-80. Go to original source... Go to PubMed...
    155. Tanaka R (2000): Protective effects of (-)-epigallocatechin gallate and (+)-catechin on paraquat-induced genotoxicity in cultured cells. Journal of Toxicological Sciences 25, 199-204. Go to original source... Go to PubMed...
    156. Terao J, Piskula M, Yao Q (1994): Protective effect of epicatechin, epicatechin gallate, and quercetin on lipid peroxidation in phospholipid bilayers. Archives of Biochemistry and Biophysics 308, 278-284. Go to original source... Go to PubMed...
    157. Thielecke F, Boschmann M (2009): The potential role of green tea catechins in the prevention of the metabolic syndrome - A review. Phytochemistry 70, 11-24. Go to original source... Go to PubMed...
    158. Tokuda H, Harada A, Hirade K, Matsuno H, Ito H, Kato K, Oiso Y, Kozawa O (2003): Incadronate amplifies prostaglandin F2α-induced vascular endothelial growth factor synthesis in osteoblasts. Enhancement of MAPK activity. Journal of Biological Chemistry 278, 18930-18937. Go to original source... Go to PubMed...
    159. Tokuda H, Takai S, Matsushima-Nishiwaki R, Akamatsu S, Hanai Y, Hosoi T, Harada A, Ohta T, Kozawa O (2007): (-)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/ JNK activation in osteoblasts. Journal Cellular Biochemistry 100, 1146-1153. Go to original source... Go to PubMed...
    160. Toyoshima Y, Okubo S, Toda M, Hara Y, Shimamura T (1994): Effect of catechin on the ultrastructure of Trichophyton mentagrophytes. Kansenshogaku Zasshi 68, 295-303. Go to original source... Go to PubMed...
    161. Tsukamoto S, Hirotsu K, Kumazoe M, Goto Y, Sugihara K, Suda T, Tsurudome Y, Suzuki T, Yamashita S, Kim Y, Huang Y, Yamada K, Tachibana H (2012): Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase C delta and acid sphingomyelinase through a 67 kDa laminin receptor in multiple myeloma cells. Biochemical Journal 443, 525-534. Go to original source... Go to PubMed...
    162. Tsukamoto S, Huang Y, Umeda D, Yamada S, Yamashita S, Kumazoe M, Kim Y, Murata M, Yamada K, Tachibana H (2014): 67-kDa laminin receptor-dependent protein phosphatase 2A (PP2A) activation elicits melanoma-specific antitumor activity overcoming drug resistance. Journal of Biological Chemistry 289, 32671-32681. Go to original source... Go to PubMed...
    163. Uchida S, Ozaki M, Akashi T, Yamashita K, Niwa M, Taniyama K (1995): Effects of (-)-epigallocatechin-3-O-gallate (green tea tannin) on the life span of stroke-prone spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology 22, 302-313. Go to original source... Go to PubMed...
    164. Ullmann U, Haller J, Decourt JP, Girault J, Richrd-Caudron AS, Pineau B, Weber P (2003): A single ascending dose study of epigallocatechin gallate in healthy volunteers. Journal of International Medical Research 31, 88-101. Go to original source... Go to PubMed...
    165. Umeda D, Yano S, Yamada K, Tachibana H (2008): Green tea polyphenol epigallocatechin-3-gallate signalling pathway through 67-kDa laminin receptor. Journal of Biological Chemistry 283, 3050-3058. Go to original source... Go to PubMed...
    166. Unno T, Takeo T (1995): Absorption of (-)-epigallocatechin gallate into the circulation system of rats. Bioscience and Biotechnology Biochemistry 59, 1558-1559. Go to original source... Go to PubMed...
    167. Vali B, Rao LG, El-Sohemy A (2007): Epigallocatechin3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. Journal of Nutritional Biochemistry 18, 341-347. Go to original source... Go to PubMed...
    168. Viacava P, Naccarato AG, Collecchi P, Menard S, Castronovo V, Bevilacqua G (1997): The spectrum of 67-kD laminin receptor expression in breast carcinoma progression. Journal of Pathology 182, 36-44. Go to original source...
    169. Wang H, Bian S, Yang CS (2011): Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1α. Carcinogenesis 32, 1881-1889. Go to original source... Go to PubMed...
    170. Weber JM, Ruzindana-Umunyana A, Imbeault L, Sircar S (2003): Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Research 58, 167-173. Go to original source... Go to PubMed...
    171. Weisburger JH (1996): Tea antioxidants and health. In: Cadenas E, Packer L (eds): Handbook of Antioxidants. Marcel Dekker, New York. 469-486.
    172. Weiss DJ, Anderton CR (2003): Determination of catechins in matcha green tea by micellar electrokinetic chromatography. Journal of Chromatography A 1011, 173-180. Go to original source... Go to PubMed...
    173. Weiss DJ, Austria EJ, Anderton CR, Hompesch R, Jander A (2006): Analysis of green tea extract dietary supplements by micellar electrokinetic chromatography. Journal of Chromatography A 1117, 103-108. Go to original source... Go to PubMed...
    174. Wright LP, Aucamp JP, Apostolides Z (2001): Analysis of black tea theaflavins by nonaqueous capillary electrophoresis. Journal of Chromatography A 919, 205-213. Go to original source... Go to PubMed...
    175. Wu L, Zhang QL, Zhang XY, Lv C, Li J, Yuan Y, Yin FX (2012): Pharmacokinetics and blood-brain barrier penetration of (+)-catechin and (-)-epicatechin in rats by microdialysis sampling coupled to high-performance liquid chromatography with chemiluminescence detection. Journal of Agricultural and Food Chemistry 60, 9377-9383. Go to original source... Go to PubMed...
    176. Wu Q, Wang M, Simon JE (2003): Determination of proanthocyanidins in grape products by liquid chromatography/mass spectrometric detection under low collision energy. Analytical Chemistry 75, 2440-2444. Go to original source... Go to PubMed...
    177. Xu J, Xu Z, Zheng W (2017): A review of the antiviral role of green tea catechins. Molecules 22, 1337. Go to original source... Go to PubMed...
    178. Yamaguchi K, Honda M, Ikigai H, Hara Y, Shimamura T (2002): Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Research 53, 19-34. Go to original source... Go to PubMed...
    179. Yamani T, Matsumoto H, Kikuoka N, Nakatani H, Uya K, Takahashi T (1996): Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis. Cancer 77, 1662-1667. Go to original source...
    180. Yamauchi J, Takai S, Matsushima-Nishiwaki R, Hanai Y, Doi T, Kato H, Ogura S, Kato K, Tokuda H, Kozawa O (2007): (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts. Prostaglandins, Leukotriens and Essential Fatty Acids 77, 173-179. Go to original source... Go to PubMed...
    181. Yan J, Feng Z, Liu J, Shen W, Wang Y, Wertz K, Weber P, Long J, Liu J (2012): Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic GotoKakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate. Journal of Nutritional Biochemistry 23, 716-724. Go to original source... Go to PubMed...
    182. Yang H, Wei CL, Liu HW, Wu JL, Li ZG, Zhang L, Jian JB, Li YY, Tai YL, Zhang J, Zhang ZZ, Jiang CJ, Xia T, Wan XC (2016): Genetic divergence between Camellia sinensis and its wild relatives revealed via genome-wide SNPs from RAD sequencing. PloS One 11, doi: 10.1371/journal.pone.0151424. Go to original source... Go to PubMed...
    183. Yashin A, Nemzer B, Yashin Y (2012): Bioavailability of tea components. Journal of Food Research 1, 281-290. Go to original source...
    184. Yuskavage JK (2008): Epigallocatechin gallate in the regulation of insulin secretion. [Msc Thesis.] Virginia Polytechnic Institute and State University, USA. 53 pp.
    185. Zhang Y, Duan W, Owusu L, Wu D, Xin X (2015): Epigallocatechin3gallate induces the apoptosis of hepatocellular carcinoma LM6 cells but not noncancerous liver cells. International Journal of Molecular Medicine 35, 117-124. Go to original source... Go to PubMed...
    186. Zhang Z, Ding Y, Dai X, Wang J, Li Y (2011): Epigallocatechin-3-gallate protects proinflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. European Journal of Pharmacology 670, 311-316. Go to original source... Go to PubMed...
    187. Zhao B, Guo Q, Xin W (2001): Free radical scavenging by green tea polyphenols. Methods in Enzymolology 335, 217-231. Go to original source... Go to PubMed...
    188. Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ (1989): Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cellular Biophysics 14, 175-185. Go to original source... Go to PubMed...
    189. Zhou J, Farah BL, Sinha RA, Wu Y, Singh BK, Bay BH, Yang CS, Yen PM (2014): Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PloS One 9, doi: 10.1371/journal.pone.0087161. Go to original source... Go to PubMed...
    190. Zhu M, Chen Y, Li R (2000): Oral absorption and bioavailability of tea catechins. Planta Medica 66, 444-447. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content